drug

von willebrand factor (recombinant)

Marketedupdated 4mo ago

by Baxalta Inc

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying von willebrand factor (recombinant)

phase3A Study of Recombinant Von Willebrand Factor (rVWF) in Chinese Participants With Von Willebrand Disease (vWD)recruitingn=20

News(1)

After tasting IPO success, Hemab’s CEO seeks ‘flavor of a multi-product coagulation company’
With the post-IPO quiet period having come to an end, CEO Benny Sørensen, M.D., Ph.D., was free to sit down with Fierce to map out Hemab’s future.
fiercebiotech · 1mo ago

Data sources

ClinicalTrials.gov

last refreshed 4h ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

von willebrand factor (recombinant)

Marketedupdated 4mo ago

by Baxalta Inc

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying von willebrand factor (recombinant)

phase3A Study of Recombinant Von Willebrand Factor (rVWF) in Chinese Participants With Von Willebrand Disease (vWD)recruitingn=20

News(1)

After tasting IPO success, Hemab’s CEO seeks ‘flavor of a multi-product coagulation company’
With the post-IPO quiet period having come to an end, CEO Benny Sørensen, M.D., Ph.D., was free to sit down with Fierce to map out Hemab’s future.
fiercebiotech · 1mo ago

Data sources

ClinicalTrials.gov

last refreshed 4h ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

von willebrand factor (recombinant)

all catalysts(0)

Trials studying von willebrand factor (recombinant)

News(1)

Report a data issue

comments(0)

von willebrand factor (recombinant)

all catalysts(0)

Trials studying von willebrand factor (recombinant)

News(1)

Report a data issue

comments(0)